CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,895,524 | -23.3% | 142,980 | -37.3% | 0.02% | -25.0% |
| Q2 2023 | $5,076,649 | +3.0% | 228,167 | +0.3% | 0.02% | -9.1% |
| Q1 2023 | $4,928,646 | +1197.6% | 227,546 | +1116.7% | 0.02% | +1000.0% |
| Q4 2022 | $379,838 | -20.2% | 18,702 | +0.8% | 0.00% | -33.3% |
| Q3 2022 | $476,000 | +163.0% | 18,555 | +143.1% | 0.00% | +200.0% |
| Q2 2022 | $181,000 | +18.3% | 7,632 | +12.2% | 0.00% | 0.0% |
| Q1 2022 | $153,000 | +112.5% | 6,805 | +87.8% | 0.00% | – |
| Q4 2021 | $72,000 | +9.1% | 3,624 | +7.6% | 0.00% | -100.0% |
| Q3 2021 | $66,000 | -9.6% | 3,368 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $73,000 | -23.2% | 3,331 | -16.2% | 0.00% | 0.0% |
| Q1 2021 | $95,000 | +1483.3% | 3,975 | +1706.8% | 0.00% | – |
| Q4 2020 | $6,000 | +200.0% | 220 | +83.3% | 0.00% | – |
| Q3 2020 | $2,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |